Medicare Part D coverage · methylprednisolone · RxCUI 260330
methylprednisolone 4 MG Oral Tablet [Medrol]
Per the CMS 2026 Part D formulary file, methylprednisolone 4 MG Oral Tablet [Medrol] is covered by 76 Medicare Part D plans (1.5% of enrollable products), averaging Tier 2.5, with prior authorization required on 50% of covering formularies.
- 1.5%
- Plan coverage
- 76
- Plans covering
- T2.5
- Avg tier
- 50%
- Prior auth required
What the CMS Formulary Data Shows for methylprednisolone 4 MG Oral Tablet [Medrol]
Per the CMS 2026 Part D formulary file, methylprednisolone 4 MG Oral Tablet [Medrol] (RxNorm concept RXCUI 260330, generic name methylprednisolone) appears on 2 distinct formulary files spanning 76 Medicare Part D plan offerings - 1.5% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.5.
Real-world access to methylprednisolone 4 MG Oral Tablet [Medrol] depends on utilization management as much as tier placement: 50% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 4,135,771 Part D beneficiaries filled methylprednisolone 4 MG Oral Tablet [Medrol] in 2023, with total plan-and-beneficiary spending of $53,086,287 and an average per-beneficiary annual cost of $12.84. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry methylprednisolone 4 MG Oral Tablet [Medrol] today.
Coverage Details
- Formularies covering
- 2
- Plans covering
- 76
- Coverage rate
- 1.5%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 50% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 4,135,771
- Total spending
- $53,086,287
- Avg per beneficiary
- $12.84
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering methylprednisolone 4 MG Oral Tablet [Medrol]
76 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Hamaspik Medicare Choice (HMO D-SNP) | Hamaspik, Inc. | T1 | No | $0 | NY |
| Hamaspik Medicare Select (HMO D-SNP) | Hamaspik, Inc. | T1 | No | $34.50 | NY |
| SCAN Connections (HMO D-SNP) | Scan Health Plan | T4 | Yes | $0 | CA |
| SCAN Connections at Home (HMO D-SNP) | Scan Health Plan | T4 | Yes | $0 | CA |
| SCAN Classic (HMO) | Scan Health Plan Nevada, Inc. | T4 | Yes | $0 | NV |
| SCAN Balance (HMO C-SNP) | Scan Health Plan Nevada, Inc. | T4 | Yes | $0 | NV |
| SCAN Strive (HMO C-SNP) | Scan Health Plan Nevada, Inc. | T4 | Yes | $0 | NV |
| SCAN MyChoice (HMO) | Scan Health Plan Nevada, Inc. | T4 | Yes | $0 | NV |
| SCAN Classic (HMO) | Scan Desert Health Plan, Inc. | T4 | Yes | $0 | AZ |
| SCAN Balance (HMO C-SNP) | Scan Desert Health Plan, Inc. | T4 | Yes | $0 | AZ |
| SCAN Embrace (HMO-POS I-SNP) | Scan Desert Health Plan, Inc. | T4 | Yes | $0 | AZ |
| SCAN Strive (HMO C-SNP) | Scan Desert Health Plan, Inc. | T4 | Yes | $0 | AZ |
| SCAN MyChoice (HMO) | Scan Desert Health Plan, Inc. | T4 | Yes | $0 | AZ |
| SCAN Classic WA (HMO) | Scan Health Plan (WA) | T4 | Yes | $0 | WA |
| SCAN MyChoice WA (HMO) | Scan Health Plan (WA) | T4 | Yes | $0 | WA |
| SCAN Classic (HMO) | Scan Health Plan (NM) | T4 | Yes | $0 | NM |
| SCAN Balance (HMO C-SNP) | Scan Health Plan (NM) | T4 | Yes | $0 | NM |
| SCAN Strive (HMO C-SNP) | Scan Health Plan (NM) | T4 | Yes | $0 | NM |
| SCAN MyChoice (HMO) | Scan Health Plan (NM) | T4 | Yes | $0 | NM |
| SCAN Classic (HMO) | Scan Health Plan | T4 | Yes | $0 | CA |
Show the next 30 plans
| SCAN Classic (HMO) | Scan Health Plan | T4 | Yes | $0 | CA |
| SCAN Classic (HMO) | Scan Health Plan | T4 | Yes | $0 | CA |
| SCAN Classic (HMO) | Scan Health Plan | T4 | Yes | $0 | CA |
| SCAN Classic (HMO) | Scan Health Plan | T4 | Yes | $0 | CA |
| SCAN Classic (HMO) | Scan Health Plan | T4 | Yes | $0 | CA |
| SCAN Classic (HMO) | Scan Health Plan | T4 | Yes | $0 | CA |
| SCAN Balance (HMO C-SNP) | Scan Health Plan | T4 | Yes | $0 | CA |
| SCAN Prime (HMO) | Scan Health Plan | T4 | Yes | $0 | CA |
| SCAN Classic (HMO) | Scan Health Plan | T4 | Yes | $0 | CA |
| SCAN Balance (HMO C-SNP) | Scan Health Plan | T4 | Yes | $0 | CA |
| SCAN Classic (HMO) | Scan Health Plan | T4 | Yes | $0 | CA |
| SCAN Balance (HMO C-SNP) | Scan Health Plan | T4 | Yes | $0 | CA |
| SCAN Alta (HMO) | Scan Health Plan | T4 | Yes | $0 | CA |
| SCAN Venture (HMO) | Scan Health Plan | T4 | Yes | $0 | CA |
| SCAN Venture (HMO) | Scan Health Plan | T4 | Yes | $0 | CA |
| SCAN Embrace (HMO I-SNP) | Scan Health Plan | T4 | Yes | $0 | CA |
| SCAN Embrace (HMO I-SNP) | Scan Health Plan | T4 | Yes | $0 | CA |
| SCAN Embrace (HMO-POS I-SNP) | Scan Health Plan | T4 | Yes | $0 | CA |
| SCAN Affirm partnered with Included LGBTQ+ Health (HMO) | Scan Health Plan | T4 | Yes | $0 | CA |
| SCAN Affirm partnered with Included LGBTQ+ Health (HMO) | Scan Health Plan | T4 | Yes | $0 | CA |
| SCAN Strive (HMO C-SNP) | Scan Health Plan | T4 | Yes | $0 | CA |
| SCAN Strive (HMO C-SNP) | Scan Health Plan | T4 | Yes | $0 | CA |
| SCAN Inspired by women for women (HMO) | Scan Health Plan | T4 | Yes | $0 | CA |
| SCAN Classic (HMO) | Scan Health Plan | T4 | Yes | $0 | CA |
| SCAN Balance (HMO C-SNP) | Scan Health Plan | T4 | Yes | $0 | CA |
| SCAN Balance (HMO C-SNP) | Scan Health Plan | T4 | Yes | $0 | CA |
| SCAN Balance (HMO C-SNP) | Scan Health Plan | T4 | Yes | $0 | CA |
| SCAN Balance (HMO C-SNP) | Scan Health Plan | T4 | Yes | $0 | CA |
| SCAN Affirm partnered with Included LGBTQ+ Health (HMO) | Scan Health Plan | T4 | Yes | $0 | CA |
| SCAN MyChoice (HMO) | Scan Health Plan | T4 | Yes | $0 | CA |
Showing top 50 of 76 plans.
Frequently Asked Questions
Is methylprednisolone 4 MG Oral Tablet [Medrol] covered by Medicare Part D?
Yes, methylprednisolone 4 MG Oral Tablet [Medrol] is covered by 76 Medicare Part D plans (1.5% of all Part D formularies).
What tier is methylprednisolone 4 MG Oral Tablet [Medrol] on Medicare Part D plans?
methylprednisolone 4 MG Oral Tablet [Medrol] averages Tier 2.5 across Part D plans, ranging from Tier 1 to Tier 4.
Does methylprednisolone 4 MG Oral Tablet [Medrol] require prior authorization?
50% of Part D formularies require prior authorization for methylprednisolone 4 MG Oral Tablet [Medrol]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on methylprednisolone 4 MG Oral Tablet [Medrol]?
In 2023, total Medicare Part D spending on methylprednisolone 4 MG Oral Tablet [Medrol] was $53,086,287, covering 4,135,771 beneficiaries. The average spend per beneficiary was $12.84.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
Similar prior-authorization rate
- 0.2 ML adalimumab-atto 50 MG/ML Prefilled Syringe [Amjevita] 50% PA
- prednisolone 15 MG Disintegrating Oral Tablet [Orapred] 50% PA
- trazodone hydrochloride 10 MG/ML Oral Solution [Raldesy] 50% PA
- lactulose 20000 MG Powder for Oral Solution 50% PA
- memantine hydrochloride 10 MG Oral Tablet 50% PA
- 168 HR estradiol 0.00104 MG/HR Transdermal System [Climara] 50% PA